UK's Life Sciences at Crossroads: Investment Trends and Challenges
Published on: Sept. 16, 2025, 9:39 p.m. | Source: Devdiscourse
The UK's declining investment in medicines is causing concerns, with major pharmaceutical firms like Merck and AstraZeneca re-evaluating their operations. Science Minister Patrick Vallance highlights issues in the valuation and access to medicines, urging a reversal in spending trends to foster innovation and benefit the NHS.
